holding steady now , page-2

Good base on the bid of optimistic ASI followers. Its nice to have a higher base from which to launch as we move through H1. I suspect the stock will get more of a kick when the ASI guys move it from a radioactive buy to a normal buy.

Further the ASI guys talk about the importance of the current trial. As we know from previous TIS trials they are able to release the results progressively so we should get a good feed of info as we move through the year and that process should de-risk the stock nicely into their commercialisation plans (TIS reckons by Sep-10)